We are live on ! Find out more
NPSP

NPS PHARMACEUTICALS INC
NPSP

Delisted

NPSP was delisted on the 20th of February, 2015.

Back to rankings

1 hedge funds and large institutions have $17.8M invested in NPS PHARMACEUTICALS INC in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 209 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less capital invested

Capital invested by funds: $3.63B → $17.8M (-$3.61B)

100% less funds holding

Funds holding: 213 → 1 (-212)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 209

Holders
1
Holders Change
-212
Holders Change %
-99.53%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
209
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$573M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$313M
3
JHIU
Janus Henderson Investors US
Colorado
-$218M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$213M
5
Wells Fargo
Wells Fargo
California
-$199M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
26
UBS AM
Illinois
– -$32.8M -918,197 Closed
ACH
27
ArrowMark Colorado Holdings
Colorado
– -$31M -865,323 Closed
PCM
28
Penn Capital Management
Pennsylvania
– -$30.7M -857,621 Closed
Norges Bank
29
Norges Bank
Norway
– -$27.7M -774,302 Closed
TA
30
Teachers Advisors
New York
– -$25.5M -712,420 Closed
CPM
31
Chesapeake Partners Management
Maryland
– -$25.1M -700,756 Closed
TCIM
32
TIAA CREF Investment Management
New York
– -$24.9M -695,375 Closed
TCM
33
Tekla Capital Management
Massachusetts
– -$22.4M -625,900 Closed
Geode Capital Management
34
Geode Capital Management
Massachusetts
– -$21.2M -592,487 Closed
Morgan Stanley
35
Morgan Stanley
New York
– -$20.1M -562,047 Closed
AAMU
36
Amundi Asset Management US
Massachusetts
– -$18.8M -524,878 Closed
VOYA Investment Management
37
VOYA Investment Management
Georgia
– -$18M -503,098 Closed
T. Rowe Price Associates
38
T. Rowe Price Associates
Maryland
– -$17.1M -478,065 Closed
Asset Management One
39
Asset Management One
Japan
– -$17.2M -465,908 Closed
PAM
40
Panagora Asset Management
Massachusetts
– -$15.7M -438,564 Closed
Allianz Asset Management
41
Allianz Asset Management
Germany
– -$15.4M -431,933 Closed
HCM
42
Harvey Capital Management
Florida
– -$15.4M -431,475 Closed
FCE
43
Fiera Capital (Europe)
Cayman Islands
– -$3.25K -426,250 Closed
Macquarie Group
44
Macquarie Group
Australia
– -$14.5M -405,952 Closed
Bank of America
45
Bank of America
North Carolina
– -$14.2M -396,136 Closed
Lord, Abbett & Co
46
Lord, Abbett & Co
New Jersey
– -$13.4M -375,601 Closed
EA
47
Emerald Advisers
Pennsylvania
– -$13M -363,906 Closed
Charles Schwab
48
Charles Schwab
California
– -$12.4M -347,966 Closed
JP Morgan Chase
49
JP Morgan Chase
New York
– -$11.8M -328,744 Closed
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
– -$10.9M -303,791 Closed
1
2
3 4 5

NPSP Hedge Fund Activity: Q1 2015 in Review

1 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q1 2015, worth a combined $17.8M — down 100% from $3.63B a quarter earlier.

Sellers outnumbered buyers: 209 funds closed out of NPSP and 0 opened new positions — a net loss of 209 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $573M sold.

  • 1 institutional investor held NPS PHARMACEUTICALS INC (NPSP) as of Q1 2015, down from 213 in Q4 2014.
  • Funds reported $17.8M of NPS PHARMACEUTICALS INC stock for Q1 2015, down 100% quarter-over-quarter.
  • 0 funds opened new NPS PHARMACEUTICALS INC positions in Q1 2015 and 209 closed out, a net change of -209 holders.
  • The largest NPS PHARMACEUTICALS INC seller in Q1 2015 was Fidelity Investments, an estimated $573M sold.

Based on aggregated 13F filings for Q1 2015.